Successful Bid for the World Conference of Science

22 August

veski is delighted to have supported the successful bid for the 2006 World Conference of Science Journalists.

The successful bid recognises Victoria's status as a major global player in science and technology. Victoria secured the event ahead of other cities, including Munich, Trieste, Beijing and Barcelona.

The conference will attract around 200 international and 200 interstate delegates and it will raise the State's international profile, particularly among the scientific community, attracting new investment and visitors to Victoria.

The 2004 conference held in Montreal from 4-8 October attracted delegates from 60 countries, with the program boasting a welcome from renowned writer Arthur C. Clarke.

Four Nobel Prize winners, five Pulitzer Prize winners and senior editors and journalists from major publications, including The Washington Post, The New York Times, New Scientist, Scientific American, The Times, Time, Reader's Digest and Le Monde also attended.

The World Conference of Science Journalists is a biannual event overseen by the World Federation of Science Journalists.

The successful bid for 2006 was put together under the auspices of the Australian Science Communicators with the help of funding from veski.

The four-day event is likely to attract a number of high profile science journalists from major publications such as Scientific American, Nature, Science and New Scientist.

It will offer a unique opportunity to showcase Australian and, in particular, Victorian science and technology to many of the world's leading science journalists.

You can view the bid documents online at www.scienceinmelbourne2006.org

What's On

June

S M T W T F S
 
 
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 

What people say about veski

“Our research program is focused on working with industrial partners to develop novel therapeutics that will transform the treatment of chronic inflammatory diseases such as IBD.”

- Professor Colby Zaph

Tweets from @veskiorg